ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
PTP 概念
1,815.39
-1.7322
-0.10%
涨家数:
14
跌家数:
20
平家数:
2
市盈率:
- -
高:
1,830.69
开:
1,817.30
低:
1,813.27
收:
1,817.12
成交量:
2,127.55万
成交额:
8.10亿
市值:
3,451.56亿
流通市值:
2,254.24亿
数据加载中...
总览
新闻资讯
联盟资源伙伴公司同日整改后监管令解除 安全事件零伤亡
美股速递
·
04/08
BUZZ-日产量下降,美国天然气公司股票上涨
路透中文
·
04/07
GLP-1口服药扩大肥胖治疗市场 吸引不愿接受注射治疗的患者
环球市场播报
·
04/07
歌礼制药-B(01672):每日一次口服小分子GLP-1R激动剂ASC30与每日一次口服小分子胰淀素选择性胰淀素受体激动剂ASC39的固定剂量复方制剂进行临床开发
智通财经
·
04/07
GLP-1长效化又有新看点:派格生物(02565)CR059入选ADA LBA 月度给药潜力受到关注
智通财经
·
04/07
Martin Midstream Partners L.P. 将循环信贷额度从1.3亿美元削减至1.15亿美元
美股速递
·
04/07
全新ES8用户的生活AB面是_____?
蔚来
·
04/06
SuperEx 指南:ET 介绍,SuperEx web3.0 的重要里程碑
链捕手
·
04/02
诺和诺德称:口服版Wegovy减肥效果优于礼来GLP‑1口服药
环球市场播报
·
04/02
首个国产长效GLP-1产品成绩单出炉,银诺医药一年亏3.4亿,GLP-1价格战已经打响
蓝鲸财经
·
04/02
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4590/news?page=2®ion=SGP"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4590","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4590\",,,,,undefined,":{"symbol":"BK4590","market":"US","secType":"PLATE","nameCN":"PTP 概念","latestPrice":1815.3914,"timestamp":1776369599999,"preClose":1817.1235,"halted":0,"volume":21275534,"delay":0,"changeRate":-0.000953,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-1.732178,"latestTime":"04-16 16:00:00 EDT","open":1817.296,"high":1830.6927,"low":1813.2699,"amount":810381375.927671,"amplitude":0.009588,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.155492,"peRate":15.905199,"turnoverRate":0.002868,"increases":14,"decrements":20,"flats":2,"marketCap":345156385293,"floatMarketCap":225423503170.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4590\",,,,,undefined,":{"symbol":"BK4590","high":1830.6927,"amplitude":0.009588,"preClose":1817.1235,"low":1813.2699,"pbRate":"3.155492","latestPrice":1815.3914,"volume":21275534,"delay":0,"open":1817.296,"prevYearClose":1575.9897,"prevWeekClose":1831.3918,"prevMonthClose":1841.3569,"prevQuarterClose":1841.3569,"fiveDayClose":1835.5848,"twentyDayClose":1810.4636,"sixtyDayClose":1705.6141,"secType":"PLATE","market":"US","turnoverRate":0.002868,"peRate":15.905199,"marketCap":345156385293,"floatMarketCap":225423503170.5,"timestamp":1776369599999,"nameCN":"PTP 概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4590\",,,,undefined,":{"bkCode":"BK4590","up":14,"down":20,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4590\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1134166635","title":"联盟资源伙伴公司同日整改后监管令解除 安全事件零伤亡","url":"https://stock-news.laohu8.com/highlight/detail?id=1134166635","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134166635?lang=zh_cn&edition=fundamental","pubTime":"2026-04-08 04:24","pubTimestamp":1775593458,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会最新披露文件,联盟资源伙伴公司(Alliance Resource Partners LP)在采取整改措施后,当日即获得监管机构解除相关指令。该事件未造成人员伤亡报告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARLP","BK4156","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625195939","title":"BUZZ-日产量下降,美国天然气公司股票上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2625195939","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625195939?lang=zh_cn&edition=fundamental","pubTime":"2026-04-07 22:15","pubTimestamp":1775571312,"startTime":"0","endTime":"0","summary":"4月7日 - ** 美国天然气公司股价上涨,追随天然气期货上涨 NGA/** 美国天然气期货NGc1上涨 2.2%,报每百万英国热量单位 2.87 美元。** 日产量初步下降,天然气价格上涨 ** 尽管预测未来两周天气温和,需求低于此前预期,而且流向美国液化天然气出口工厂的天然气日产量下降,但价格仍有所上涨。** 天然气 ETF 也上涨,美国天然气基金UNG.P上涨 2.5%,ProShares Ultra Bloomberg 天然气BOIL.P上涨 4.7%(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"37684715aaf54a73b9fe52ee56a263cc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nL4T40Q12A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0368265418.SGD","NEXT","LU0456854461.SGD","IE00BMG7P694.USD","IE00BMG7P587.USD","LU2237443382.USD","LU1621768115.EUR","IE00B29SXK94.USD","LU0251142724.SGD","LU0266512127.USD","IE00BLSP4452.SGD","LNG","ET","IE00BMG7P819.SGD","LU2463526074.USD","IE00BN8TJ469.HKD","LU0314104364.USD","BK4144","IE00B29SXL02.USD","LU0345781412.USD","IE00BLSP4239.USD","LU0345770308.USD","BOIL","LU0170899867.USD","LU0251131958.USD","LU2237443549.SGD","IE00BBT3K403.USD","LU2449327464.USD","LU0630314457.HKD","LU1621767737.EUR","LU0320765489.SGD","IE00BMG7P702.HKD","BK4581","LU1621767810.EUR","LU2237443978.SGD","LU0208291251.USD","LU2237443895.HKD","LU0048573561.USD","LU2237443622.USD","LU0070302665.USD","BK4585","BK4590","LU0345770993.USD","LU0788109394.HKD","LU0266512473.USD","LU2384288077.EUR","WMB","LU0122376428.USD","LU1621768206.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625895579","title":"GLP-1口服药扩大肥胖治疗市场 吸引不愿接受注射治疗的患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2625895579","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625895579?lang=zh_cn&edition=fundamental","pubTime":"2026-04-07 21:37","pubTimestamp":1775569020,"startTime":"0","endTime":"0","summary":"诺和诺德的口服Wegovy正在吸引那些原本不愿接受注射治疗的新患者,而礼来正准备推出口服药参与竞争;早期需求表明该品类正在实现超越患者转换的自然增长。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:张俊 SF065","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-07/doc-inhtsvwu0132077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4144","GLP","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625627937","title":"歌礼制药-B(01672):每日一次口服小分子GLP-1R激动剂ASC30与每日一次口服小分子胰淀素选择性胰淀素受体激动剂ASC39的固定剂量复方制剂进行临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2625627937","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625627937?lang=zh_cn&edition=fundamental","pubTime":"2026-04-07 19:34","pubTimestamp":1775561655,"startTime":"0","endTime":"0","summary":"智通财经APP讯,歌礼制药-B 发布公告,董事会宣布已选定ASC30_39 FDC,即每日一次口服小分子GLP-1R激动剂ASC30与每日一次口服小分子胰淀素选择性胰淀素受体激动剂ASC39的固定剂量复方制剂,进行临床开发。“据我们所知,这是首个公开宣布的口服GLP-1与口服胰淀素复方制剂,选定这一固定剂量复方制剂是开发ASC30与ASC39新型潜在协同口服复方制剂治疗肥胖的重要一步。”","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425546.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01672","BK1161","01477","BK1515","BK4590","BK4144","BK1574","GLP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625932346","title":"GLP-1长效化又有新看点:派格生物(02565)CR059入选ADA LBA 月度给药潜力受到关注","url":"https://stock-news.laohu8.com/highlight/detail?id=2625932346","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625932346?lang=zh_cn&edition=fundamental","pubTime":"2026-04-07 19:00","pubTimestamp":1775559600,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,派格生物近期凭借核心管线CR059入选美国糖尿病协会科学年会Late Breaking Abstract,再度把市场目光拉回到其circRNA-LNP技术平台上。circRNA-LNP技术:跳出传统GLP-1长效化思路的新尝试派格生物CR059的核心看点,来自其自主研发的circRNA-LNP技术平台。总体来看,派格生物这次因CR059入选ADA LBA而受到关注,并不只是因为拿到了一个学术会议席位,更因为它把公司在GLP-1长效化方向上的技术路线,再次推到了聚光灯下。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02565","BK4144","GLP","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176239888","title":"Martin Midstream Partners L.P. 将循环信贷额度从1.3亿美元削减至1.15亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176239888","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176239888?lang=zh_cn&edition=fundamental","pubTime":"2026-04-07 04:10","pubTimestamp":1775506211,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会(SEC)的文件显示,Martin Midstream Partners L.P. (MMLP) 已将其循环信贷额度进行了调整。该公司将原有的信贷融资规模从1.3亿美元下调至1.15亿美元,减少了1500万美元。\n这一变动反映了公司对其资本结构和流动性管理的持续优化。循环信贷额度是企业短期融资的重要工具,额度的调整通常与公司的资金需求、市场融资条件以及财务策略密切相关。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MMLP","BK4144","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625627945","title":"全新ES8用户的生活AB面是_____?","url":"https://stock-news.laohu8.com/highlight/detail?id=2625627945","media":"蔚来","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625627945?lang=zh_cn&edition=fundamental","pubTime":"2026-04-06 11:00","pubTimestamp":1775444400,"startTime":"0","endTime":"0","summary":"全新ES8,作为你的全场景科技旗舰座驾陪你从容开启生活中的每一面A面商务从容:天空屏助你从容了解业务进展超大后备箱为你收纳商务所需飞航零重力座椅陪你小憩充电超大前备舱装下全部商务行程……B面自在松弛:天空屏沉浸观影后备箱满载欢乐飞航零重力座椅伴赏山景超大前备舱装下你的自在远行……每一刻从容时光都属于...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzI4NjAxMzM2Mg==&mid=2750373044&idx=1&sn=939e5420d5ac87c071d8a51f485102f8&chksm=cc570a5749a98cd2e16caa6db33272671fa21f73027fd611f218e3da2fe9000d0d5e3861bfa0&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4526","BK4135","LU0052750758.USD","LU0320764599.SGD","NIO","NIO.SI","BK4590","BK4532","09866","LU0128526141.USD","NIOG","BK4534","BK4585","LU0029874061.USD","BK4555","BK4574","BK4598","BK4505","BK4509","LU0708995583.HKD","EVS.SI","BK4504","BK4531","BK4099","BK4588","BK4581","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624507743","title":"SuperEx 指南:ET 介绍,SuperEx web3.0 的重要里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=2624507743","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624507743?lang=zh_cn&edition=fundamental","pubTime":"2026-04-02 22:38","pubTimestamp":1775140687,"startTime":"0","endTime":"0","summary":" ET 为 SuperEx Super Chain 生态计划提供经济基础与动力中枢,标志着 SuperEx 在构建 Web3.0 生态进程中的关键里程碑。 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2256415","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4588","BK4585","BK4561","BK4144","ET","BK4590"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624501755","title":"诺和诺德称:口服版Wegovy减肥效果优于礼来GLP‑1口服药","url":"https://stock-news.laohu8.com/highlight/detail?id=2624501755","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624501755?lang=zh_cn&edition=fundamental","pubTime":"2026-04-02 21:02","pubTimestamp":1775134920,"startTime":"0","endTime":"0","summary":"诺和诺德周四表示,口服版 Wegovy 的平均减重效果显著优于礼来本周刚获批的竞品药物 Foundayo。诺和诺德称,另一项分析显示,84% 的患者更偏好与 Wegovy 相似的药物特性,而非 Foundayo。 此前研究显示,口服 Wegovy 平均减重幅度达16.6%;而坚持完成疗程的患者服用 Foundayo 后,平均减重约12.4%。 自 1 月初口服 Wegovy 在美国上市以来,处方量飙升,已有超 60 万名患者开始服用。 诺和诺德周四称,最新研究结果表明,口服 Wegovy 具备差异化竞争力。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-02/doc-inhtcnfs0874567.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4585","IE00BFSS8Q28.SGD","LU1232071149.USD","IE00BJJMRY28.SGD","LU0154236417.USD","LU2361045086.USD","LU1551013425.SGD","LU2361044865.SGD","LU0006306889.USD","LU0061475181.USD","LU0109391861.USD","LU1548497426.USD","LU1868837136.USD","LU2471134796.USD","SG9999001176.SGD","SG9999017495.SGD","LU1551013342.USD","LU2236285917.USD","LU0354030511.USD","LU0672654240.SGD","LU0256863902.USD","LU2089283258.USD","LU2265009873.SGD","LU2552382058.USD","LU2106854487.HKD","LU0158827948.USD","LU1127390331.HKD","LLY","LU0203201768.USD","IE00BKDWB100.SGD","IE00B4R5TH58.HKD","LU0234572021.USD","IE00BZ1G4Q59.USD","LU0238689110.USD","IE00BFSS7M15.SGD","LU1069344957.HKD","BK4588","LU2750360997.AUD","SG9999014914.USD","SG9999001176.USD","LU0114720955.EUR","LU2491050071.SGD","LU0708995401.HKD","LU1366192091.USD","LU2264538146.SGD","LU2357305700.SGD","IE00BK4W5M84.HKD","LU1988902786.USD","LU2471134952.CNY","LU2417539215.USD","LU0058720904.USD","BK4007","IE0009355771.USD","LU1093756325.SGD","LU2063271972.USD","SG9999018857.SGD","LU2111349929.HKD","LU0786609619.USD","LU0198837287.USD","SG9999014880.SGD","LU0889565916.HKD","LU0823434583.USD","LU0456855351.SGD","LU0787776722.HKD","LU2211815571.USD","LU0820562030.AUD","SGXZ81514606.USD","LU1035775433.USD","LU2324357040.USD","LU2746668461.USD","IE00BFTCPJ56.SGD","LU0964807845.USD","IE00B7KXQ091.USD","LU1057294990.SGD","LU2462157665.USD","LU2089984988.USD","LU0320765059.SGD","LLYX","LU0471298694.HKD","LU2237443622.USD","LU0320765992.SGD","LLYZ","LU0323591593.USD","IE00BJT1NW94.SGD","LU1814569148.SGD","SG9999015978.USD","BK4144","LU1629891620.HKD","LU2023251221.USD","LU0097036916.USD","LU2602419157.SGD","SG9999015986.USD","IE0002141913.USD","SGXZ31699556.SGD","LU2552382132.HKD","LU0385154629.USD","LU1712237335.SGD","LU0266013472.USD","LU0466842654.USD","LU2456880835.USD","BK4534","LU0106261372.USD","LU1061106388.HKD","LU0316494557.USD","LU1291159041.SGD","BK4533","LU0943347566.SGD","LU0823434740.USD","IE00BJLML261.HKD","LU1989771016.USD","LU2168564495.EUR","LU0417517546.SGD","LU0823416689.USD","LU0354030438.USD","LU2237443465.HKD","LU2108987350.USD","BK4581","LU1267930730.SGD","IE00B2B36J28.USD","LU1868836591.USD","BK4532","IE00B1BXHZ80.USD","LU1064131342.USD","LU0640476718.USD","LU2028103732.USD","LU0471298777.SGD","LU0210536198.USD","LU2089284900.SGD","ELIL","BK4516","LU1720051108.HKD","IE0004445015.USD","LU1145028129.USD","LU1093756168.USD","SG9999014906.USD","LU2491049909.HKD","LU2237443382.USD","LU2237443549.SGD","BK4590","LU1804176565.USD","SG9999013999.USD","LU0820561818.USD","SG9999014898.SGD","IE00BJJMRX11.SGD","BK4599","LU0158827781.USD","IE00B1XK9C88.USD","LU2168564222.USD","LU2896262040.SGD","LLII","LU2237443978.SGD","LU2756315664.SGD","NVO","LU0882574055.USD","IE00BJJMRZ35.SGD","IE00B775H168.HKD","LU1023059063.AUD","SG9999018865.SGD","LU0353189680.USD","LU2168563687.JPY","IE00BKVL7J92.USD","IE00BN29S564.USD","LU0289739699.SGD","LU0256863811.USD","LU0353189763.USD","IE0001KFT4U8.USD","LU2023250330.USD","LU1280957306.USD","LU1623119135.USD","IE00BKPKM429.USD","LU2168564149.EUR","IE0005OL40V9.USD","SGXZ51526630.SGD","LU2750360641.GBP","NVOX","SG9999015945.SGD","LU2471134879.HKD","LU0432979614.USD","LU0094547139.USD","LU2023250504.SGD","LU2168564065.EUR","GB00BDT5M118.USD","LU0689472784.USD","LU1868836757.USD","LU0109394709.USD","LU2552382215.SGD","SGXZ57979304.SGD","LU2491050154.USD","LU2468319806.SGD","LU2360106947.USD","ELIS","IE00B4JS1V06.HKD","LU0683600562.USD","SG9999015952.SGD","LU1868837300.USD","LU0882574139.USD","LU0096364046.USD","LU1868836914.USD","LU2361044949.HKD","LU0079474960.USD","IE0004445239.USD","LU1917777945.USD","LU2087625088.SGD","LU2237438978.USD","LU2461242641.AUD","LU1974910355.USD","LU1983299246.USD","LU2471134523.USD","LU0122379950.USD","IE00BWXC8680.SGD","LU2213496289.HKD","LU2756315318.SGD","LU1720051017.SGD","LU2237443895.HKD","LU2112291526.USD","SGXZ99366536.SGD","IE00BK4W5L77.USD","LU2271345857.HKD","NVOH","LU0203202063.USD","LU0225283273.USD","LU1323610961.USD","LU2746668974.SGD","LU0820561909.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624212503","title":"首个国产长效GLP-1产品成绩单出炉,银诺医药一年亏3.4亿,GLP-1价格战已经打响","url":"https://stock-news.laohu8.com/highlight/detail?id=2624212503","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624212503?lang=zh_cn&edition=fundamental","pubTime":"2026-04-02 19:11","pubTimestamp":1775128291,"startTime":"0","endTime":"0","summary":"可以预见,随着大量仿制药涌入,GLP-1的价格将面临进一步巨大冲击,而GLP-1价格战已经悄然打响。2025年6月,玛仕度肽获NMPA批准用于肥胖或超重成人的慢性体重管理。在国内,目前还没有专门为“减肥”适应症获批上市的口服GLP-1药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1775118515212957683","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4590","BK4144","GLP","02591","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":30,"code":"91000000","status":"200"}]}}